文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌

幽门螺杆菌通过失调肠道免疫并诱导黏液降解微生物群特征促进结直肠癌发生

Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
PubMed 文献 · Gut · 2023-04-04

该研究用幽门螺杆菌感染两种Apc突变小鼠模型和C57BL/6小鼠,发现感染加速肿瘤发展,伴随调节性T细胞和促炎性T细胞减少、STAT3信号激活及杯状细胞丢失;在感染患者结肠活检中见到类似免疫与上皮改变;无菌饲养改善、早期抗生素根除使肿瘤发生率正常化。

要点

  • 幽门螺杆菌感染加速Apc突变小鼠的肿瘤发展。
  • 感染诱导调节性T细胞和促炎性T细胞减少的免疫改变特征。
  • 早期抗生素根除幽门螺杆菌使肿瘤发生率降至未感染对照水平。

核心结论

  • 研究提供证据表明幽门螺杆菌感染是结直肠癌发生的强效因果促进因素。
  • 作者认为应考虑将幽门螺杆菌状态纳入结直肠癌预防措施。

研究设计与样本

  • 研究感染两种Apc突变小鼠模型和C57BL/6小鼠,用流式细胞术、芯片细胞术、免疫组化和单细胞RNA测序分析肠道免疫与上皮特征。
  • 在无菌小鼠和粪便移植实验中表征微生物特征,并评估感染者结肠活检。

主要发现

  • 幽门螺杆菌感染加速Apc突变小鼠的肿瘤发展。
  • 感染诱导以调节性T细胞和促炎性T细胞减少为特征的独特免疫改变。
  • 感染诱导肠道和结肠上皮促癌STAT3信号及杯状细胞丢失。
  • 感染患者结肠活检中可见类似免疫与上皮改变。
  • 无菌饲养改善Apc突变小鼠肿瘤发展,早期抗生素根除使肿瘤发生率正常化至未感染对照水平。

临床怎么用

  • 作者认为应考虑将幽门螺杆菌状态纳入结直肠癌预防措施。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Helicobacter pylori infection is the most prevalent bacterial infection worldwide. Besides being the most important risk factor for gastric cancer development, epidemiological data show that infected individuals harbour a nearly twofold increased risk to develop colorectal cancer (CRC). However, a direct causal and functional connection between H. pylori infection and colon cancer is lacking. DESIGN: We infected two Apc-mutant mouse models and C57BL/6 mice with H. pylori and conducted a comprehensive analysis of H. pylori-induced changes in intestinal immune responses and epithelial signatures via flow cytometry, chip cytometry, immunohistochemistry and single cell RNA sequencing. Microbial signatures were characterised and evaluated in germ-free mice and via stool transfer experiments. RESULTS: H. pylori infection accelerated tumour development in Apc-mutant mice. We identified a unique H. pylori-driven immune alteration signature characterised by a reduction in regulatory T cells and pro-inflammatory T cells. Furthermore, in the intestinal and colonic epithelium, H. pylori induced pro-carcinogenic STAT3 signalling and a loss of goblet cells, changes that have been shown to contribute-in combination with pro-inflammatory and mucus degrading microbial signatures-to tumour development. Similar immune and epithelial alterations were found in human colon biopsies from H. pylori-infected patients. Housing of Apc-mutant mice under germ-free conditions ameliorated, and early antibiotic eradication of H. pylori infection normalised the tumour incidence to the level of uninfected controls. CONCLUSIONS: Our studies provide evidence that H. pylori infection is a strong causal promoter of colorectal carcinogenesis. Therefore, implementation of H. pylori status into preventive measures of CRC should be considered.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Ralser A, Dietl A, Jarosch S, et al. Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature. Gut. 2023. PMID: 37015754. doi:10.1136/gutjnl-2022-328075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。